Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evidence for unified assessment criteria of HER2 IHC in colorectal carcinoma
    Meeting Abstract

    Evans, M.; Krause, H.; Elliott, A.; Lou, E.; Ghani, H.; Yantiss, R.; Garcia-Buitrago, M.; Shia, J.; Yaeger, R.; Oberley, M.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
    Journal Article

    Bercz, A.; Park, B. K.; Pappou, E.; Nemirovsky, D.; Sarkar, R.; Yamner, M.; Omer, D.; Verheij, F. S.; Alvarez, J.; Atri, P.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)
    Meeting Abstract

    de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer - Evaluating radiation, ablation, and surgery (ERASur)
    Meeting Abstract

    Hitchcock, K.; Romesser, P. B.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The impact of Wnt pathway alterations including RNF43, GNAS, CTNNB1, and APC on prognosis and potential therapeutic vulnerability in pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Takebe, N.; Blais, E. M.; Huynh, J.; Thach, D.; de Arbeloa, P. M.; Matrisian, L. M.; Petricoin, E.; Pishvaian, M. J.; Chung, V.; Boland, P. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • BRAF variants and oncogenic fusions to define sporadic MMR-deficient colorectal cancer subtypes
    Meeting Abstract

    Abdelfattah, S.; Harada, G.; Patel, S.; Artz, O.; Yaeger, R.; Johannet, P.; Harrold, E.; Walch, H. S.; Argiles, G.; Rousseau, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of LY3537982, a potent and highly selective KRAS G12C inhibitor in KRAS G12C-mutant GI cancers: Results from a phase 1 study
    Meeting Abstract

    Hollebecque, A.; Kuboki, Y.; Murciano-Goroff, Y. R.; Yaeger, R.; Cassier, P. A.; Heist, R. S.; Fujiwara, Y.; Deming, D. A.; Ammakkanavar, N.; Patnaik, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1b study of sotorasib combined with panitumumab as second-line treatment of KRAS G12C-mutated colorectal cancer
    Meeting Abstract

    Yaeger, R.; Langer, C. J.; Ruffinelli, J. C.; Fakih, M.; Furqan, M.; Machiels, J. P. H.; Saportas, Y.; Nolte-Hippenmeyer, J.; Chan, E.; Xia, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Early identification and treatment of occult metastatic disease in stage III colon cancer (SU2C ACT3 clinical trial)
    Meeting Abstract

    Pappas, L.; Yaeger, R.; Kasi, P. M.; Shah, M. A.; Azad, N. S.; Horick, N. K.; Corcoran, R. B.; Diaz, L. A.; Parikh, A. R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Local excision to enhance organ preservation in rectal cancer after favorable response to total neoadjuvant therapy
    Meeting Abstract

    Bercz, A.; Rosen, R.; Drescher, M.; Gonen, M.; Shia, J.; Nishimura, M.; Romesser, P. B.; Crane, C. H.; Saltz, L. B.; Cercek, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save